Oncology Learning Network· @OncLearnNetwork · X·· 2 天前评分70
正文 · 机器翻译
🚨#ARTEMIS011 的结果表明，risvutatug rezetecan 显著改善了既往接受过大量治疗的复发或难治性 #osteosarcoma 患者的 PFS，为一种潜在的新治疗选择提供了支持。
了解更多：https://www.hmpgloballearningnetwork.com/site/onc/news/risvutatug-rezetecan-reduces-progression-risk-67-previously-treated-relapsed-or
#ESMO26 #MedTwitter
9 浏览 · 0 赞 · 0 转发 · 0 回复
会议摘要
LBA13按 Proffered paper 1: Breast cancer, early and advanced stage 对上
Trastuzumab rezetecan (SHR-A1811) in HER2-low advanced breast cancer (BC): A randomized, phase 3 study (HORIZON-Breast06)
https://esmocongress.esmo.org来源：Oncology Learning Network · x.com